AU2020310616A1 - Method and system for determining glucose change in a subject - Google Patents

Method and system for determining glucose change in a subject Download PDF

Info

Publication number
AU2020310616A1
AU2020310616A1 AU2020310616A AU2020310616A AU2020310616A1 AU 2020310616 A1 AU2020310616 A1 AU 2020310616A1 AU 2020310616 A AU2020310616 A AU 2020310616A AU 2020310616 A AU2020310616 A AU 2020310616A AU 2020310616 A1 AU2020310616 A1 AU 2020310616A1
Authority
AU
Australia
Prior art keywords
meal
subject
glucose
model parameters
innovation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020310616A
Other languages
English (en)
Inventor
Anas EL FATHI
Ahmad Haidar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2020310616A1 publication Critical patent/AU2020310616A1/en
Priority to AU2023278117A priority Critical patent/AU2023278117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/725—Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Databases & Information Systems (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Data Mining & Analysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2020310616A 2019-07-09 2020-07-09 Method and system for determining glucose change in a subject Abandoned AU2020310616A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023278117A AU2023278117A1 (en) 2019-07-09 2023-12-08 Method and system for determining glucose change in a subject

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962871931P 2019-07-09 2019-07-09
US62/871,931 2019-07-09
PCT/IB2020/056467 WO2021005552A1 (en) 2019-07-09 2020-07-09 Method and system for determining glucose change in a subject

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023278117A Division AU2023278117A1 (en) 2019-07-09 2023-12-08 Method and system for determining glucose change in a subject

Publications (1)

Publication Number Publication Date
AU2020310616A1 true AU2020310616A1 (en) 2022-01-20

Family

ID=74114442

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2020310616A Abandoned AU2020310616A1 (en) 2019-07-09 2020-07-09 Method and system for determining glucose change in a subject
AU2023278117A Abandoned AU2023278117A1 (en) 2019-07-09 2023-12-08 Method and system for determining glucose change in a subject

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023278117A Abandoned AU2023278117A1 (en) 2019-07-09 2023-12-08 Method and system for determining glucose change in a subject

Country Status (7)

Country Link
US (1) US20220280720A1 (https=)
EP (1) EP3997712A4 (https=)
JP (2) JP7463491B2 (https=)
CN (1) CN114127860A (https=)
AU (2) AU2020310616A1 (https=)
CA (1) CA3146060A1 (https=)
WO (1) WO2021005552A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12569619B2 (en) * 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
WO2022169856A1 (en) * 2021-02-03 2022-08-11 Abbott Diabetes Care Inc. Systems, devices, and methods relating to medication dose guidance
FR3139456B1 (fr) * 2022-09-13 2026-02-27 Diabeloop Système permettant de compenser un repas imprévu ingéré
FR3139659B1 (fr) * 2022-09-13 2026-02-27 Diabeloop Système permettant d'estimer un repas imprévu ingéré

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6575905B2 (en) * 2000-09-22 2003-06-10 Knobbe, Lim & Buckingham Method and apparatus for real-time estimation of physiological parameters
AU2014349078B2 (en) * 2013-11-14 2019-07-25 Regents Of The University Of California Glucose rate increase detector: a meal detection module for the health monitoring system
US10646650B2 (en) * 2015-06-02 2020-05-12 Illinois Institute Of Technology Multivariable artificial pancreas method and system
US10478556B2 (en) * 2016-03-04 2019-11-19 Roche Diabetes Care, Inc. Probability based controller gain
US10792423B2 (en) * 2016-04-13 2020-10-06 The Trustees Of The University Of Pennsylvania Methods, systems, and computer readable media for physiology parameter-invariant meal detection
CA3198598A1 (en) * 2017-05-05 2018-11-08 Eli Lilly And Company Closed loop control of physiological glucose
WO2019125932A1 (en) * 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose

Also Published As

Publication number Publication date
EP3997712A4 (en) 2023-07-12
JP2022539818A (ja) 2022-09-13
EP3997712A1 (en) 2022-05-18
WO2021005552A1 (en) 2021-01-14
CA3146060A1 (en) 2021-01-14
JP7785832B2 (ja) 2025-12-15
JP2024099522A (ja) 2024-07-25
CN114127860A (zh) 2022-03-01
AU2023278117A1 (en) 2024-01-04
US20220280720A1 (en) 2022-09-08
JP7463491B2 (ja) 2024-04-08

Similar Documents

Publication Publication Date Title
CN110869075B (zh) 人工胰岛系统中的胰岛素残余活性含量计算
JP7785832B2 (ja) 被験者のグルコース変化を判定するための方法
EP2986215B1 (en) Discretionary insulin delivery systems and methods
US20120226259A1 (en) Devices, Systems and Methods for Adjusting Fluid Delivery Parameters
EP3902469B1 (en) Evaluation and visualization of glycemic dysfunction
US20200015760A1 (en) Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
EP2445407B1 (en) A method and device for improving glycemic control based on residual insulin
CN107809943A (zh) 用于分析从患有糖尿病的人测得的葡萄糖数据的方法和系统
EP3122254A1 (en) System and method for adjusting therapy based on risk associated with a glucose state
EP2603133A1 (en) Method and system for improving glycemic control
JP7802802B2 (ja) リスクベースのインスリン送達変換のためのシステム及び方法
El Fathi et al. An unannounced meal detection module for artificial pancreas control systems
Fravolini et al. An iterative learning strategy for the auto-tuning of the feedforward and feedback controller in type-1 diabetes
US11931548B2 (en) Method and system for determining optimal and recommended therapy parameters for diabetic subject
Dias et al. Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm
US12569619B2 (en) Techniques for determining automated insulin delivery dosages
Benam et al. Estimation and prediction of glucose appearance rate for use in a fully closed-loop dual-hormone intraperitoneal artificial pancreas
Rodríguez-Sarmiento et al. Practical constraint definition in safety schemes for artificial pancreas systems
US20230338654A1 (en) System and method for titrating basal insulin doses
Hamata et al. Exploring Equilibrium Points in a Long-term Glucose-insulin Model for Type I Diabetes: MPC Application in Automated Insulin Delivery Systems Using Functional Insulin Therapy Tools
Herrero et al. Enhancing an Artificial Pancreas with an Adaptive Bolus Calculator based on Case-Based Reasoning
HK1252509B (en) Methods and systems for analyzing glucose data measured from a person having diabetes

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted